2020年10月30日 · In November 2019, the Food and Drug Administration granted fast-track designation to investigation of neflamapimod to treat Lewy body dementia. As yet, no drugs …

This month we are highlighting updates from recent studies, along with new opportunities to participate in trials of potential new medications and diagnostic tests. New Data on LBD …

2024 has been an exciting year for clinical trials for people with Lewy body dementia (LBD). Over the past year, you have heard a lot from the Lewy Body Dementia Association (LBDA) about …

Clinical trials and meta-analyses now provide an evidence base for the treatment of cognitive, neuropsychiatric, and motor symptoms in patients with Lewy body dementia.

Because it is not easy to accurately diagnose, affects so many, and early attention can make a world of difference, we want everyone to join together to raise awareness about Lewy body …

2023年9月21日 · Four new papers introduce two candidates: DOPA decarboxylase (DDC), the enzyme that converts levodopa into dopamine, and mitochondrial DNA damage. People with …

2021年2月15日 · A second new LBD signal was detected within the lysosomal TMEM175 gene on chromosome 4p16.3, a known Parkinson’s disease risk locus 12.

2021年11月12日 · Recent studies indicate that the adaptive immune system plays a role in Lewy body dementia (LBD). However, the mechanism regulating T cell brain homing in LBD is …

The Lewy Body Dementia Resource Center was formed for the purpose of raising crucial awareness of Lewy body dementia (LBD) and to offer urgently needed help in New York for …

2023年5月1日 · Lewy Body Dementia is the second most frequent neurodegenerative illness proven to cause dementia, after Alzheimer's disease (AD). It is believed to be vastly …